zm 241385 has been researched along with atenolol in 1 studies
Studies (zm 241385) | Trials (zm 241385) | Recent Studies (post-2010) (zm 241385) | Studies (atenolol) | Trials (atenolol) | Recent Studies (post-2010) (atenolol) |
---|---|---|---|---|---|
401 | 3 | 124 | 5,473 | 1,950 | 852 |
Protein | Taxonomy | zm 241385 (IC50) | atenolol (IC50) |
---|---|---|---|
Beta-1 adrenergic receptor | Homo sapiens (human) | 0.7468 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.23 | |
Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.23 | |
Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.23 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartoccini, F; Carminati, P; Castorina, M; Di Cesare, MA; Di Serio, S; Gallo, G; Ghirardi, O; Giorgi, F; Giorgi, L; Minetti, P; Piersanti, G; Tarzia, G; Tinti, MO | 1 |
1 other study(ies) available for zm 241385 and atenolol
Article | Year |
---|---|
2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.
Topics: Adenine; Adenosine A2 Receptor Antagonists; Animals; Cell Line; Cricetinae; Cricetulus; Drug Design; Humans; Imidazoles; Male; Models, Molecular; Motor Activity; Purines; Radioligand Assay; Rats; Rats, Inbred F344; Structure-Activity Relationship; Triazoles | 2005 |